GlaxoSmithKline(GSK)
$50.45+0.26 (+0.51%)
GSK
GlaxoSmithKline ownership
$50.45
At close:+0.26 (+0.51%)
Want to see GSK full AI Analyst Report?
GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?
5,274 Followers
GlaxoSmithKline (GSK) Ownership Overview
- 5.87% Mutual Funds
- 7.30% Other Institutional Investors
- 0.34% ETFs
- 86.49% Public Companies and Individual Investors
The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 13.51% of the company’s stock is owned by Institutional Investors, and 86.49% is owned by Public Companies and Individual Investors.
The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 13.51% of the company’s stock is owned by Institutional Investors, and 86.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Tweedy Browne Co Llc | $3,730,237 | |
| Sep 30, 2026 | Gallacher Capital Management Llc | $267,922 | |
| Sep 30, 2026 | Dodge & Cox | $2,080,130,746 | |
| Sep 30, 2026 | Hotchkis & Wiley Capital Management Llc | $188,785,985 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| John A. Gunn | 43,183,117 | Institution | 2.13% | 2,178,588,253 |
| Dodge & Cox Funds | 39,174,382 | Institution | 1.94% | 1,976,347,572 |
| Ken Fisher | 35,351,693 | Institution | 1.75% | 1,783,492,912 |
| Theofanis Kolokotrones | 25,192,138 | Institution | 1.25% | 1,270,943,362 |
| Vanguard Chester Funds | 18,172,650 | Institution | 0.90% | 916,810,193 |
| Vanguard Wellington Fund | 9,498,942 | Institution | 0.47% | 479,221,624 |
| Fidelity Rutland Square Trust Ii | 8,522,636 | Institution | 0.42% | 429,966,986 |
| Fidelity Hastings Street Trust | 5,642,694 | Institution | 0.28% | 284,673,912 |
| Fidelity Devonshire Trust | 4,136,200 | Institution | 0.20% | 208,671,290 |
| Fidelity Securities Fund | 3,556,375 | Institution | 0.18% | 179,419,119 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dodge & Cox Funds | 39,174,382 | Institution | 1.94% | 1,976,347,572 |
| Vanguard Chester Funds | 18,172,650 | Institution | 0.90% | 916,810,193 |
| Vanguard Wellington Fund | 9,498,942 | Institution | 0.47% | 479,221,624 |
| Fidelity Rutland Square Trust Ii | 8,522,636 | Institution | 0.42% | 429,966,986 |
| Fidelity Hastings Street Trust | 5,642,694 | Institution | 0.28% | 284,673,912 |
| Fidelity Devonshire Trust | 4,136,200 | Institution | 0.20% | 208,671,290 |
| Fidelity Securities Fund | 3,556,375 | Institution | 0.18% | 179,419,119 |
| Vanguard Fenway Funds | 3,549,080 | Institution | 0.18% | 179,051,086 |
| Fidelity Financial Trust | 2,697,200 | Institution | 0.13% | 136,073,740 |
| T. Rowe Price International Funds, Inc. | 2,639,571 | Institution | 0.13% | 133,166,357 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Avantis International Equity ETF, AVDE ETF | 1,474,737 | Institution | 0.07% | 74,680,682 |
| Fidelity Enhanced International ETF, FENI ETF | 956,949 | Institution | 0.05% | 48,278,077 |
| VanEck Pharmaceutical ETF, PPH ETF | 909,450 | Institution | 0.04% | 46,054,548 |
| First Trust Value Line Dividend Index Fund, FVD ETF | 647,351 | Institution | 0.03% | 32,658,858 |
| Hartford Multifactor Developed Markets (ex-US) ETF, RODM ETF | 307,034 | Institution | 0.02% | 15,548,202 |
| GMO International Value ETF, GMOI ETF | 291,592 | Institution | 0.01% | 14,634,470 |
| Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF | 276,647 | Institution | 0.01% | 14,009,404 |
| Avantis International Large Cap Value ETF, AVIV ETF | 254,181 | Institution | 0.01% | 12,871,726 |
| Brandes International ETF, BINV ETF | 188,600 | Institution | <0.01% | 9,514,870 |
| T. Rowe Price International Equity ETF, TOUS ETF | 161,105 | Institution | <0.01% | 8,253,409 |
FAQ
What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.51% of GlaxoSmithKline (GSK) stock is held by institutional investors: 5.87% by mutual funds, 0.34% by ETFs and 7.30% by other institutional investors.
What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.49% of GlaxoSmithKline (GSK) stock is held by public companies and individual investors.
Who owns the most shares of GlaxoSmithKline (GSK)?
John A. Gunn owns the most shares of GlaxoSmithKline (GSK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

